medcitynews.comMedCity News - Healthcare technology news, life science current events

Twitter Facebook LinkedIn RSS Subscribe via email Newsletter Signup Send Tips Open navigation MedCity News Toggle Search News Health Tech BioPharma Devices & Diagnostics Consumer / Employer Contributors MedCity Influencers MedCitizens Events INVEST INVEST Digital Health ENGAGE at HLTH Podcasts Research Newsletters Newsletter Signup Send Tips Twitter Facebook LinkedIn RSS Subscribe via email Search for: Search MedCity News Daily, BioPharma, Health Tech Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business By Arundhati Parmar Legal DOJ Launches Task Force on Healthcare Monopolies: Will It Make A Difference? The U.S. Department of Justice recently launched a task force on healthcare monopolies. Experts have varying opinions on how it will impact the healthcare industry. By Marissa Plescia Daily, Startups, Providers Sutter Health Partners with Millie to Incorporate Midwifery into Its Maternal Care Model As more hospitals across the country shut down their maternity wards, a Sutter Health-owned hospital in Berkeley has taken proactive steps to ensure it can continue providing care for the pregnant people in its community. The hospital partnered with Millie, a Berkeley-based startup offering hybrid maternal care from midwives and doulas. By Katie Adams MedCity Influencers America Is Losing One of Its Most Precious Assets: Our Brain Power Investing in youth brain capital is not just a moral imperative. It is an economic necessity. By Harris A. Eyre Latest News BioPharma, Pharma Takeda Commits $100M for Chance to Bring Immunotherapy to Alzheimer’s Disease Takeda Pharmaceutical has secured an option on an Alzheimer’s disease immunotherapy from AC Immune that is on track to report its first Phase 2 data later this quarter. Exercising the option would make Takeda responsible for Phase 3 testing of the therapy, putting AC Immune in line for up to $2.1 billion in milestone payments. By Frank Vinluan Events Healthcare Investment Trends Take Center Stage at MedCity INVEST The boutique healthcare investment conference in Chicago is scheduled for May 21-22. Space is limited so register today! By Stephanie Baum Sponsored Post With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge? Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions. BioPharma, Pharma Lycia Therapeutics Lands $106M for Protein Degraders That Treat Autoimmune & Inflammatory Diseases Eli Lilly-partnered Lycia Therapeutics will use its Series C financing to continue developing its internal pipeline of protein-degrading drugs. The startup is working to reach the clinic with drugs for autoimmune and inflammatory disorders. By Frank Vinluan Daily, Providers, Medical Education Medical Residents Are Increasingly Avoiding States With Abortion Restrictions According to new statistics from the Association of American Medical Colleges, for the second year in a row, students graduating from U.S. medical schools were less likely to apply this year for residency positions in states with abortion bans and other significant abortion restrictions. By Julie Rovner, KFF Health News and Rachana Pradhan Hospitals, Providers ‘Two-Sided Green’: How 4 Health Systems Are Saving Money With Renewable Energy Hospitals are seeking to offset their expenses any way they can, and some are taking a two-sided green” approach — meaning pursuing renewable energy initiatives that will save money in the long run. These hospitals are on track to save millions, and some already have. By Katie Adams MedCity News Daily Newsletter Sign up and get the latest news in your inbox. Enter your email address Subscribe Now We will never sell or share your information without your consent. See our privacy policy . Sponsored Post A Personalized Approach to Medication Nonadherence At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes. sponsored content A Deep-dive Into Specialty Pharma A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS. By PurpleLab MedCity Influencers Healthcare’s Next Void to Fill: Digital Primary Care No matter what form they take, one thing is clear — there is an urgent demand for digital primary care providers to guide patient navigation in the digital health era. By Ed Liebowitz Health Tech, Payers Mental Health Platform Wave Gains First Payer Contract Wave is now in network with Aetna in California, giving 3 million members access to the company’s mental health services. By Marissa Plescia eBook Using Informed Awareness to Transform Care Coordination and Improve the Clinical and Patient Experience This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness. By Care Logistics Daily, BioPharma, Health Tech This Chip Seeks to Transform Drug Manufacturing by Learning More About Intracellular Dynamics A new startup launched at the SynBioBeta conference. The company, called CybergenX, is seeking to integrate AI-powered cybergenetic technology into the synthetic biology field. By doing this, CybergenX is seeking to accelerate the potential of engineering biology in drug manufacturing. By Katie Adams Health Tech ŌURA Unveils 2 New Features for Heart Health ŌURA announced two new heart health features on Friday: one that estimates cardiovascular age and one that measures cardio capacity. By Marissa Plescia MedCity Influencers Small Thank You’s Mean a Lot: The Impact of Micropayments in Clinical Trials Micropayments provide an additional incentive for patients to complete required tests, procedures, and diary entries, ensuring that sites, sponsors, and CROs are able to collect the required data needed to complete a clinical trial on time and on budget. By Tanya Kogan BioPharma BioLabs Pegasus Park Cultivates Life Science Ecosystem Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas. MedCitizens StartUPDATES: New Developments from Healthcare Startups Check out news from Alpha Sophia, Triomics, In-House Health, and Humanaut Health. By Stephanie Baum BioPharma Astellas CEO Q&A (Part 1): There Is No Playbook on Cell and Gene Therapies A Q&A with Naoki Okamura revealed that when it comes to cell and gene therapies, the CEO of Astellas Pharma believes risk-taking is a must for eventual success. By Arundhati Parmar Health Tech, Hospitals, Providers Ascension Hospitals Across Several States Are Offline Following Cyberattack On Wednesday, Ascension noticed that a hacker had infiltrated its systems. As the health system works with Mandiant to investigate the incident, clinical services remain disrupted at Ascension facilities across several states. By Katie Adams Payers, Providers Why Consumers Leave Their Payer/Provider Many consumers leave their provider because of navigation problems, while many leave their insurer because of experience issues, a new Accenture report found. By Marissa Plescia MedCity Influencers Why Personalized Medicine Should Not Be Too Personalized One irony of personalized or precision medicine (PM) is that it aims, against the advice of Hippocrates and Osler, to treat the disease, not the patient. By...